Cargando…

A Molecular Basis for Selective Antagonist Destabilization of Dopamine D(3) Receptor Quaternary Organization

The dopamine D(3) receptor (D(3)R) is a molecular target for both first-generation and several recently-developed antipsychotic agents. Following stable expression of this mEGFP-tagged receptor, Spatial Intensity Distribution Analysis indicated that a substantial proportion of the receptor was prese...

Descripción completa

Detalles Bibliográficos
Autores principales: Marsango, Sara, Caltabiano, Gianluigi, Jiménez-Rosés, Mireia, Millan, Mark J., Pediani, John D., Ward, Richard J., Milligan, Graeme
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5437050/
https://www.ncbi.nlm.nih.gov/pubmed/28522847
http://dx.doi.org/10.1038/s41598-017-02249-3
_version_ 1783237512929476608
author Marsango, Sara
Caltabiano, Gianluigi
Jiménez-Rosés, Mireia
Millan, Mark J.
Pediani, John D.
Ward, Richard J.
Milligan, Graeme
author_facet Marsango, Sara
Caltabiano, Gianluigi
Jiménez-Rosés, Mireia
Millan, Mark J.
Pediani, John D.
Ward, Richard J.
Milligan, Graeme
author_sort Marsango, Sara
collection PubMed
description The dopamine D(3) receptor (D(3)R) is a molecular target for both first-generation and several recently-developed antipsychotic agents. Following stable expression of this mEGFP-tagged receptor, Spatial Intensity Distribution Analysis indicated that a substantial proportion of the receptor was present within dimeric/oligomeric complexes and that increased expression levels of the receptor favored a greater dimer to monomer ratio. Addition of the antipsychotics, spiperone or haloperidol, resulted in re-organization of D(3)R quaternary structure to promote monomerization. This action was dependent on ligand concentration and reversed upon drug washout. By contrast, a number of other antagonists with high affinity at the D(3)R, did not alter the dimer/monomer ratio. Molecular dynamics simulations following docking of each of the ligands into a model of the D(3)R derived from the available atomic level structure, and comparisons to the receptor in the absence of ligand, were undertaken. They showed that, in contrast to the other antagonists, spiperone and haloperidol respectively increased the atomic distance between reference α carbon atoms of transmembrane domains IV and V and I and II, both of which provide key interfaces for D(3)R dimerization. These results offer a molecular explanation for the distinctive ability of spiperone and haloperidol to disrupt D(3)R dimerization.
format Online
Article
Text
id pubmed-5437050
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-54370502017-05-19 A Molecular Basis for Selective Antagonist Destabilization of Dopamine D(3) Receptor Quaternary Organization Marsango, Sara Caltabiano, Gianluigi Jiménez-Rosés, Mireia Millan, Mark J. Pediani, John D. Ward, Richard J. Milligan, Graeme Sci Rep Article The dopamine D(3) receptor (D(3)R) is a molecular target for both first-generation and several recently-developed antipsychotic agents. Following stable expression of this mEGFP-tagged receptor, Spatial Intensity Distribution Analysis indicated that a substantial proportion of the receptor was present within dimeric/oligomeric complexes and that increased expression levels of the receptor favored a greater dimer to monomer ratio. Addition of the antipsychotics, spiperone or haloperidol, resulted in re-organization of D(3)R quaternary structure to promote monomerization. This action was dependent on ligand concentration and reversed upon drug washout. By contrast, a number of other antagonists with high affinity at the D(3)R, did not alter the dimer/monomer ratio. Molecular dynamics simulations following docking of each of the ligands into a model of the D(3)R derived from the available atomic level structure, and comparisons to the receptor in the absence of ligand, were undertaken. They showed that, in contrast to the other antagonists, spiperone and haloperidol respectively increased the atomic distance between reference α carbon atoms of transmembrane domains IV and V and I and II, both of which provide key interfaces for D(3)R dimerization. These results offer a molecular explanation for the distinctive ability of spiperone and haloperidol to disrupt D(3)R dimerization. Nature Publishing Group UK 2017-05-18 /pmc/articles/PMC5437050/ /pubmed/28522847 http://dx.doi.org/10.1038/s41598-017-02249-3 Text en © The Author(s) 2017 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Article
Marsango, Sara
Caltabiano, Gianluigi
Jiménez-Rosés, Mireia
Millan, Mark J.
Pediani, John D.
Ward, Richard J.
Milligan, Graeme
A Molecular Basis for Selective Antagonist Destabilization of Dopamine D(3) Receptor Quaternary Organization
title A Molecular Basis for Selective Antagonist Destabilization of Dopamine D(3) Receptor Quaternary Organization
title_full A Molecular Basis for Selective Antagonist Destabilization of Dopamine D(3) Receptor Quaternary Organization
title_fullStr A Molecular Basis for Selective Antagonist Destabilization of Dopamine D(3) Receptor Quaternary Organization
title_full_unstemmed A Molecular Basis for Selective Antagonist Destabilization of Dopamine D(3) Receptor Quaternary Organization
title_short A Molecular Basis for Selective Antagonist Destabilization of Dopamine D(3) Receptor Quaternary Organization
title_sort molecular basis for selective antagonist destabilization of dopamine d(3) receptor quaternary organization
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5437050/
https://www.ncbi.nlm.nih.gov/pubmed/28522847
http://dx.doi.org/10.1038/s41598-017-02249-3
work_keys_str_mv AT marsangosara amolecularbasisforselectiveantagonistdestabilizationofdopamined3receptorquaternaryorganization
AT caltabianogianluigi amolecularbasisforselectiveantagonistdestabilizationofdopamined3receptorquaternaryorganization
AT jimenezrosesmireia amolecularbasisforselectiveantagonistdestabilizationofdopamined3receptorquaternaryorganization
AT millanmarkj amolecularbasisforselectiveantagonistdestabilizationofdopamined3receptorquaternaryorganization
AT pedianijohnd amolecularbasisforselectiveantagonistdestabilizationofdopamined3receptorquaternaryorganization
AT wardrichardj amolecularbasisforselectiveantagonistdestabilizationofdopamined3receptorquaternaryorganization
AT milligangraeme amolecularbasisforselectiveantagonistdestabilizationofdopamined3receptorquaternaryorganization
AT marsangosara molecularbasisforselectiveantagonistdestabilizationofdopamined3receptorquaternaryorganization
AT caltabianogianluigi molecularbasisforselectiveantagonistdestabilizationofdopamined3receptorquaternaryorganization
AT jimenezrosesmireia molecularbasisforselectiveantagonistdestabilizationofdopamined3receptorquaternaryorganization
AT millanmarkj molecularbasisforselectiveantagonistdestabilizationofdopamined3receptorquaternaryorganization
AT pedianijohnd molecularbasisforselectiveantagonistdestabilizationofdopamined3receptorquaternaryorganization
AT wardrichardj molecularbasisforselectiveantagonistdestabilizationofdopamined3receptorquaternaryorganization
AT milligangraeme molecularbasisforselectiveantagonistdestabilizationofdopamined3receptorquaternaryorganization